Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
376
-
Total 13F shares, excl. options
-
79.9M
-
Shares change
-
+4.28M
-
Total reported value, excl. options
-
$6.55B
-
Value change
-
+$414M
-
Put/Call ratio
-
0.72
-
Number of buys
-
266
-
Number of sells
-
-107
-
Price
-
$82.00
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2024
447 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q1 2024.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 376 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.9M shares
of 112M outstanding shares and own 71.19% of the company stock.
Largest 10 shareholders include FMR LLC (16.3M shares), BlackRock Inc. (8.27M shares), VANGUARD GROUP INC (7.79M shares), Avoro Capital Advisors LLC (3.59M shares), STATE STREET CORP (3.33M shares), GEODE CAPITAL MANAGEMENT, LLC (2.33M shares), ALLIANCEBERNSTEIN L.P. (1.56M shares), PICTET ASSET MANAGEMENT Holding SA (1.38M shares), VIKING GLOBAL INVESTORS LP (1.09M shares), and Voya Investment Management LLC (1.08M shares).
This table shows the top 376 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.